TriSalus Share Price

TriSalus Share Price

NASDAQ: TLSI | Micro Cap | Healthcare
$2.32
+$0.12 (5.45%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

TriSalus Stock Performance

Open
$2.20
Prev. Close
$2.20
Circuit Range
N/A
Day Range
$2.20 - $2.37
Year Range
$2.17 - $7.83
Volume
23,673
Average Traded
$2.28

TriSalus Share Price Today

As of 21 November 2026, TriSalus Life Sciences, Inc.'s share price is $2.32. The stock opened at $2.20, compared to its previous close of $2.20. During today's trading session, TriSalus Life Sciences, Inc.'s share price traded between $2.20 and $2.37, with an average price of $2.28. Over the past 52 weeks, the stock has recorded a high of $7.83 and a low of $2.17. In terms of performance, TriSalus Life Sciences, Inc.'s share price has declined by 32.16% over the last six months and is down 66.18% on a year-on-year basis.

TriSalus Share Price Chart

Line chart of the TriSalus price trend over the selected period. The price rose overall, ranging from 2.20 to 2.37, ending at 2.32.
$2.20$2.37
L
Show Current Price
H

TriSalus Stock Fundamentals & Key Indicators

Market Cap
$87.92M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.43
Revenue (TTM)
$45.15B
Return On Equity (TTM)
-3861.03%
Profit Margin
-154.35%
Debt to Equity
47.60
Quarterly Earnings Growth YoY
9.23%

TriSalus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$13.21$8.90$11.41$12.88
Net Profit-$9.75$1.54-$9.19-$8.85
Net Profit Margin-73.81%17.30%-80.54%-68.71%
Income ChangeN/A115.79%-696.75%3.70%

TriSalus Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$18.51$29.43$45.15
Net Profit-$63.60-$33.23-$69.69
Net Profit Margin-343.60%-112.91%-154.35%
Income ChangeN/A47.75%-109.72%

TriSalus Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets3.093.33.74
Current Assets32.2420.6720.86
Total Assets35.3323.9724.6
Non Current Liabilities57.6939.6436.98
Current Liabilities11.510.2314.69
Total Liabilities69.1949.8751.66
Shareholders' Equity-33.86-25.89-27.07

TriSalus Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-18.01-40.84-50.58
Investing-0.84-0.35-1.59
Financing30.7637.9454.63

About TriSalus

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

TriSalus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$3.72
$2.31
-37.60%
Oct 2026
$4.20
$3.71
-14.22%
Sep 2026
$5.09
$4.33
-12.45%
Aug 2026
$4.56
$4.94
+8.81%
Jul 2026
$4.53
$4.54
-0.33%
Jun 2026
$3.33
$4.55
+33.19%
May 2026
$4.34
$3.42
-20.56%
Apr 2026
$4.15
$4.30
+7.36%
Mar 2026
$5.02
$4.01
-20.44%
Feb 2026
$4.86
$5.04
+1.41%
Jan 2026
$6.95
$4.97
-28.59%
Dec 2025
$6.75
$6.96
+1.46%

TriSalus Share Price FAQs